References
- Al-Sarraf M, LeBlanc M, Giri PGS, Fu KK, Cooper J. (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol. 16:1310–17.
- Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. (2006). Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately chemetogenic chemotherapy despite antiemetic treatment. J Clin Oncol. 24:4472–78.
- Cohen L, De Moor CA, Eisenberg P, Ming EE, Hu H. (2007). Chemotherapy-induced nausea and vomiting: Incidence and impact on patient quality of life at community oncology settings. Supportive Care Cancer. 15:497–503.
- Cure´ VC H, Adenis A, Mathieu NT, Niezgodzki G, Kwiatkowski F, Pezet D, Perpoint B, Coudert B, Focan C, Chipponi FL,J, et al. (2002). Phase II Trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer. J Clin Oncol. 20:1175–81.
- Edgar RS, Green EW, Zhao Y, Van Ooijen G, Olmedo M, Qin X, Xu Y, Pan M, Valekunja UK, Feeney KA, et al. (2012). Peroxiredoxins are conserved markers of circadian rhythms. Nature. 485:459–64.
- Hareyama M, Sakata K, Shirato H, Nishioka T, Nishio M, Suzuki K, Saitoh A, Oouchi A, Fukuda S, Himi T. (2002). A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer. 94:2217–23.
- Hrushesky W. (1985). Circadian_timing_of_cancer_chemotherapy. Science. 228:73–75.
- Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Iacobelli S, Genet D, et al, Chronotherapy Group of the European Organization for R, Treatment of C. (2009). Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–07.
- Jin F, Wu WL, Li YY, Long JH, He MY, Zeng L. (2014). Induction chrono-chemotherapy plus radiation therapy for nasopharyngeal carcinoma: A phase 2 prospective randomized study. Int J Radiat Oncol Biol Phys. 88:491.
- Levi F. (2006). Chronotherapeutics: The relevance of timing in cancer therapy. Cancer Causes Control. 17:611–21.
- Lévi F. (2001). Circadian chronotherapy for human cancers. Lancet Oncol. 2:307–15.
- Levi F, Benavides M, Chevelle C, Le Saunier F, Bailleul F, Misset JL, Regensberg C, Vannetzel JM, Reinberg A, Mathe G. (1990). Chemotherapy of advanced ovarian cancer with 4ʹ-O-tetrahydropyranyl doxorubicin and cisplatin: A randomized phase II trial with an evaluation of circadian timing and dose-intensity. J Clin Oncol. 8:705–14.
- Levi F, Focan C, Karaboue A, De La Valette V, Focan-Henrard D, Baron B, Kreutz F, Giacchetti S. (2007). Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv Drug Deliv Rev. 59:1015–35.
- Lévi F, Zidani R, Misset J-L. (1997). Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet. 350:681–86.
- Lin HX, Hua YJ, Chen QY, Luo DH, Sun R, Qiu F, Mo HY, Mai HQ, Guo X, Xian LJ, et al. (2013). Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Chin J Cancer. 32:502–11.
- Ma J, Mai H-Q, Hong M-H, Min H-Q, Mao Z-D, Cui N-J, Lu T-X, Mo H-Y. (2001). Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol. 19:1350–57.
- Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, Parker BA, Ancoli-Israel S. (2012). Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 10:202–16.
- Zarogoulidis P, Darwiche K, Kalamaras G, Huang H, Hohenforst-Schmidt W, Zarogoulidis K. (2013). Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancer. Translational Lung Cancer Res. 2:E17–22.
- Zeng ZL, Sun J, Guo L, Li S, Wu MW, Qiu F, Jiang WQ, Levi F, Xian LJ. (2005). Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients. Chronobiol Int. 22:741–54.
- Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. (2008). Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 8:59–73.